It has been a pandemic since at least biblical times, and unless effective strategies harness the global tuberculosis scourge, the disease will remain problematic and pervasive—an unending plague throughout many regions ...
In March, at the start of the COVID-19 pandemic, there was a consensus among health care providers and public health officials that a vaccine that provided complete immunity to SARS-CoV-2, the virus that causes COVID-19, ...
Oct 21, 2020
0
11
A state-owned Chinese drugmaker is setting up production lines to supply 1 billion doses of two possible coronavirus vaccines that are being tested on 50,000 people in 10 countries, the company chairman said Tuesday.
Oct 20, 2020
0
1
Scientists called for urgent action to improve public trust in immunisation as research suggested sizeable minorities in some nations may be reluctant to be vaccinated against COVID-19.
Oct 20, 2020
2
52
The chain breaks here, in a tiny medical clinic in Burkina Faso that went nearly a year without a working refrigerator.
Oct 19, 2020
0
0
Athletes understand that there are two very different approaches that can be taken when training their bodies. For example, lifting heavy weights is a great way to achieve maximum strength. In contrast, low-load high-repetition ...
Oct 8, 2020
0
3
Seasonal influenza vaccine development and mass production, as well as three international influenza vaccine cardiovascular outcomes trials currently underway, may inform future efforts targeted at developing and evaluating ...
Oct 5, 2020
0
3
Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published this week in the Journal of ...
Oct 1, 2020
0
3
New discoveries about the immune response made against a particular part of the COVID-19 virus in children who have the rare but dangerous multisystem inflammatory syndrome in children, or MIS-C, may have important implications ...
Sep 25, 2020
0
5
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development ...
Sep 24, 2020
0
2
